Important differences exist between second generation antidepressants

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7007.751a (Published 16 September 1995) Cite this as: BMJ 1995;311:751
  1. John J Ferguson,
  2. Peter J Smith,
  3. Martin G V Jenkins
  1. Medical director Director, pharmaceutical advisory services Pharmaceutical division manager Prescription Pricing Authority, Newcastle upon Tyne NE1 6SN

    EDITOR,--I M Anderson and B M Tomenson discuss the relative tolerability of second generation antidepressants and state: “However, they are of minor importance clinically in terms of numbers of prescriptions and, with regard to cost effectiveness analyses, many …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription